| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2003 | WO2003102153A2 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 12/11/2003 | WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102116A2 Oil-soluble pigment compositions |
| 12/11/2003 | WO2003102097A1 The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102012A2 New etonogestrel esters |
| 12/11/2003 | WO2003102010A1 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
| 12/11/2003 | WO2003101996A2 Esters in position 20 of camptothecins |
| 12/11/2003 | WO2003101995A2 Camptothecins with a modified lactone ring |
| 12/11/2003 | WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/11/2003 | WO2003101993A1 Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents |
| 12/11/2003 | WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 12/11/2003 | WO2003101990A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 12/11/2003 | WO2003101989A1 Inhibitors of jak and cdk2 protein kinases |
| 12/11/2003 | WO2003101988A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 12/11/2003 | WO2003101987A1 3-substituted quinuclidines and their use |
| 12/11/2003 | WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 12/11/2003 | WO2003101982A1 Nicotine-containing, controlled release composition and method |
| 12/11/2003 | WO2003101981A1 Novel substituted indoles |
| 12/11/2003 | WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 12/11/2003 | WO2003101979A1 Anthelmintic and insecticidal thiophene derivatives |
| 12/11/2003 | WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators |
| 12/11/2003 | WO2003101970A1 Imidazolium cxcr3 inhibitors |
| 12/11/2003 | WO2003101968A1 Pyrazole compound and medicinal composition containing the same |
| 12/11/2003 | WO2003101965A1 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use |
| 12/11/2003 | WO2003101963A1 Opioid receptor antagonists |
| 12/11/2003 | WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/11/2003 | WO2003101961A1 Novel substituted indoles |
| 12/11/2003 | WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | WO2003101957A1 New salts |
| 12/11/2003 | WO2003101956A1 Pharmaceutical combination |
| 12/11/2003 | WO2003101951A2 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 12/11/2003 | WO2003101950A2 Methods for enhancing motor performance and/or endurance |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 12/11/2003 | WO2003101923A2 Policosanol compositions, extraction from novel sources, and uses thereof |
| 12/11/2003 | WO2003101539A1 Self-administered contraceptive injection of oily solution |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof |
| 12/11/2003 | WO2003101492A2 Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain |
| 12/11/2003 | WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR |
| 12/11/2003 | WO2003101490A1 Drug composition containing calcium channel antagonist |
| 12/11/2003 | WO2003101489A1 Medicinal composition for treatment for digestive tract disease |
| 12/11/2003 | WO2003101488A1 Bacterial transforming agent |
| 12/11/2003 | WO2003101487A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 12/11/2003 | WO2003101481A1 Treatment of neurodegenerative diseases using proteasome modulators |
| 12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin |
| 12/11/2003 | WO2003101474A1 Combination chemotherapy with chlorotoxin |
| 12/11/2003 | WO2003101470A1 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid |
| 12/11/2003 | WO2003101469A1 An oral composition with insulin-like activities and methods of use |
| 12/11/2003 | WO2003101468A1 Method for the protection of endothelial and epithelial cells during chemotherapy |
| 12/11/2003 | WO2003101467A1 Pharmaceutical compositions comprising abacavir and lamivudine |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101465A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 12/11/2003 | WO2003101464A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 12/11/2003 | WO2003101463A1 Method and agent for the prevention, inhibition and treatment of sepsis |
| 12/11/2003 | WO2003101462A2 Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment |
| 12/11/2003 | WO2003101461A1 Norethindrone sustained release formulations and methods associated therewith |
| 12/11/2003 | WO2003101460A1 External preparations for treating dermatitis |
| 12/11/2003 | WO2003101459A1 Antagonizing nk1 receptors inhibits consumption of substances of abuse |
| 12/11/2003 | WO2003101458A1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 12/11/2003 | WO2003101457A1 Peritoneal dialysis solution with taurolidine |
| 12/11/2003 | WO2003101456A1 Use of compounds that stimulate cgmp |
| 12/11/2003 | WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 12/11/2003 | WO2003101454A1 A buffered, liquid nicotine composition for pulmonary administration |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101452A1 Process for the preparation of highly pure rabeprazole sodium salt |
| 12/11/2003 | WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/11/2003 | WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 12/11/2003 | WO2003101447A1 Ischemic reperfusion arrhythmia inhibitors |
| 12/11/2003 | WO2003101446A1 A herbal molecule as potential anti-leukemic drug |
| 12/11/2003 | WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof |
| 12/11/2003 | WO2003101443A1 The use of milnacipran for the treatment of tension-type headache |
| 12/11/2003 | WO2003101442A1 Peptide deformylase inhibitors |
| 12/11/2003 | WO2003101441A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 12/11/2003 | WO2003101439A1 Medicament containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol in different formulations for treating urinary incontinence |
| 12/11/2003 | WO2003101438A1 Treatment for human papillomavirus |
| 12/11/2003 | WO2003101437A2 Method of treating asthma using fexofenadine |
| 12/11/2003 | WO2003101436A1 Novel chromium (iii) alpha amino acid complexes |
| 12/11/2003 | WO2003101434A2 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 12/11/2003 | WO2003101433A1 Plaster containing fentanyl |
| 12/11/2003 | WO2003101432A1 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/11/2003 | WO2003101430A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 12/11/2003 | WO2003101428A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 12/11/2003 | WO2003101425A2 Therapeutic agent-containing polymeric nanoarticles |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003101423A1 Immediate release pharmaceutical formulation |
| 12/11/2003 | WO2003101422A2 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 12/11/2003 | WO2003101421A1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 12/11/2003 | WO2003101419A1 Anti-parasite containing sustained release injection |
| 12/11/2003 | WO2003101403A2 USE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR)-gamma LIGANDS AS A TREATMENT FOR PITUITARY TUMORS AND ASSOCIATED CONDITIONS, SUCH AS CUSHING'S SYNDROME |
| 12/11/2003 | WO2003101402A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 12/11/2003 | WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 12/11/2003 | WO2003101390A2 Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function |